Hedge Funds Getting More Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Did Hedge Funds Make The Right Call On Ironwood Pharmaceuticals, Inc. (IRWD) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Still Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Have Never Been This Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
We hate to say this but, we told you so.
Here's What Hedge Funds Think About Ironwood Pharmaceuticals, Inc. (IRWD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Ditched Ironwood Pharmaceuticals, Inc. (IRWD) At The Right Time
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Hedge Funds Have Never Been This Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and optimism towards the resolution of the trade war with China...
Did Hedge Funds Drop The Ball On Ironwood Pharmaceuticals, Inc. (IRWD) ?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Are Betting On Ironwood Pharmaceuticals, Inc. (IRWD)
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant...
Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
